These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Nutrition and pharmacological treatment for prevention of prostate cancer]. Segev Y; Nativ O Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727 [TBL] [Abstract][Full Text] [Related]
8. The promiscuous receptor. Newsom-Davis TE; Kenny LM; Ngan S; King J; Waxman J BJU Int; 2009 Nov; 104(9):1204-7. PubMed ID: 19426197 [TBL] [Abstract][Full Text] [Related]
9. Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Bonjour JP; Chevalley T; Fardellone P Br J Nutr; 2007 Apr; 97(4):611-6. PubMed ID: 17349071 [TBL] [Abstract][Full Text] [Related]
10. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089. Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D and prostate cancer. Konety BR; Getzenberg RH Urol Clin North Am; 2002 Feb; 29(1):95-106, ix. PubMed ID: 12109360 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer prevention: past, present, and future. Fleshner N; Zlotta AR Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D and the epidemiology of prostate cancer. Schwartz GG Semin Dial; 2005; 18(4):276-89. PubMed ID: 16076349 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and cancer: new insights. Schwartz GG; Skinner HG Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):6-11. PubMed ID: 17143048 [TBL] [Abstract][Full Text] [Related]
15. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer chemoprevention: current status and future prospects. Gupta S Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer and vitamin D: what does the evidence really suggest? Barnett CM; Beer TM Urol Clin North Am; 2011 Aug; 38(3):333-42. PubMed ID: 21798396 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of prostate cancer through dietary agents: progress and promise. Syed DN; Khan N; Afaq F; Mukhtar H Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2193-203. PubMed ID: 18006906 [TBL] [Abstract][Full Text] [Related]
19. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Giovannucci E Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]